Legal Representation
Attorney
Matthew A. Homyk
USPTO Deadlines
Next Deadline
703 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-07-06)
Due Date
July 06, 2027
Grace Period Ends
January 06, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 6, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 2, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 1, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 17, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 14, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 14, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 9, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 7, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 7, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 7, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 20, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 20, 2020 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Aug 19, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 19, 2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Aug 3, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 7, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Jul 7, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 7, 2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jul 7, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 7, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 12, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 12, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 3, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 27, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 27, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 16, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 12, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Classification
International Classes
005